Navigation Links
Art's Way Manufacturing Announces Contract for Modular Swine Facility for the University of Georgia
Date:11/16/2009

ARMSTRONG, Iowa, Nov. 16 /PRNewswire-FirstCall/ -- Art's Way Manufacturing, Inc. (Nasdaq: ARTW), announces its wholly owned subsidiary, Art's Way Scientific, Inc. - Buildings For Science - will be providing 6 modular swine facilities for breeding, gestation, farrowing, nursery and finisher operations. The complex will be used to train undergraduate and graduate students in all aspects of swine production. Research projects will include trials on nutrition, physiology and meat quality. The contract is valued at approximately $1.3 million.

The facility, developed for the University of Georgia in association with the Office of University Architects and Department of Animal & Dairy Sciences, will have some unique environmental features. Methane gas generated on-site will be used to fire the boilers that treat animal wastes and minimize odors. Exhaust fans are being connected to a biofilter in order to increase air quality. Rain water will be captured and reused to help keep the animal buildings clean. Waste water from the process will be spread on adjoining fields for irrigation.

Dan Palmer, General Manager of Art's Way Scientific said, "We are very pleased to have been awarded this contract. With swine, specific attention needs to be paid to the management of effective environmental conditions, cleanable surfaces ventilation, animal pens, manure management and the quantity and quality of food and water. Our unique and modular designs address all of these key issues."

J. Ward McConnell, Jr., Executive Chairman of the Board, said, "I am gratified Art's Way Scientific's design, manufacturing, pricing and customer service was evaluated and chosen to construct this innovative research center. With this order and other opportunities we are bidding on, we are confident Art's Way Scientific will continue to contribute to the Company's overall revenue and income growth in 2009 and beyond. We continue to focus on exceeding our customers' expectations and increasing shareholder value."

About Art's Way Scientific, Inc. - Buildings for Science:

Art's Way Scientific, Inc. is a wholly owned subsidiary of Art's Way Manufacturing, Inc. It is the recognized leading supplier of modular laboratories for biocontainment, animal science, public health and security requirements. Art's Way Scientific custom designs, manufactures, delivers, and installs laboratories and research facilities to meet customers' critical requirements.

About Art's Way Manufacturing, Inc.

Art's Way manufactures and distributes farm machinery niche products including animal feed processing equipment, sugar beet defoliators and harvesters, land maintenance equipment, crop shredding equipment, plows, hay and forage equipment and top and bottom drive augers. After market service parts are also an important part of the Company's business. We have two wholly owned subsidiaries. Art's Way Vessels, Inc. manufactures pressurized tanks and vessels and Art's Way Scientific, Inc. manufactures modular animal confinement buildings and modular laboratories.

For More Information, Contact: Jim Drewitz, Investor Relations

830-669-2466 jim@jdcreativeoptions.com

Or visit the Company's website at www.artsway-mfg.com

This news release includes "forward-looking statements" within the meaning of the federal securities laws. Statements of anticipated future results are based on current expectations and are subject to a number of risks and uncertainties, including but not limited to, quarterly fluctuations in results, customer demand for the Company's products, domestic and international economic conditions, the management of growth and other risks detailed from time to time in the Company's Securities and Exchange Commission filings. Actual results may differ markedly from management's expectations. The Company cautions readers not to place undue reliance upon any such forward-looking statements.

SOURCE Art's Way Manufacturing, Inc.


'/>"/>
SOURCE Art's Way Manufacturing, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
2. Evotec Starts Phase II in Smoking Cessation with EVT 302
3. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France
4. Synosia Starts Phase II Efficacy Trial For Rufinamide
5. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in Germany
6. D-Ribose Helps Energy-Starved Hearts
7. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
8. Agent in red wine found to keep hearts young
9. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
10. Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
11. AMT Starts Collaboration With St. Jude Childrens Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Jan. 19, 2017 AquaBounty Technologies, Inc. (AIM: ... productivity in aquaculture and a majority-owned subsidiary of Intrexon ... has completed the listing of its common shares on ... from Intrexon. "AquaBounty,s listing on NASDAQ represents ... our exposure to the U.S. markets as we advance ...
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots ... scientists from around the world, was today awarded the "Best Science & Technology ... entirely on merit and decided upon by a dedicated team of researchers and ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... spanning the full spectrum of drug and device development, and Prism Clinical ... companies and clinicians, today announced Verified Clinical Trials (VCT) has been ...
(Date:1/19/2017)...  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a ... operable and inoperable solid tumor cancers, announced today that ... NW Bio, will present at the Phacilitate Immunotherapy World ... Regency Hotel in Miami, Florida . ... "New Therapeutic Approaches – Expanding the Reach of Cancer ...
Breaking Biology Technology:
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
(Date:1/12/2017)... 12, 2017 A new report by Allied Market Research, titled, ... biometric technology market is expected to generate revenue of $10.72 billion by 2022, with ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) In the ...
(Date:1/6/2017)... , Jan. 5, 2017  Delta ID Inc., a ... scanning technology for automotive at CES® 2017. Delta ID ... ) to demonstrate the use of iris scanning as ... authenticate the driver in a car, and as a ... driving experience. Delta ID and Gentex will ...
Breaking Biology News(10 mins):